India is moving closer to commercialising a new tuberculosis vaccine — the HSP Subunit Vaccine in Adjuvant (DDA). Developed ...
The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...
23h
Northern states push for stronger panchayat-led action as TB-free India workshop begins in Lucknow
Lucknow, Nov 24 (UNI) Uttar Pradesh Deputy Chief Minister Keshav Prasad Maurya stated on Monday that providing justice to ...
A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.
The HSP Subunit Vaccine candidate, jointly developed by the Institute of Life Sciences (ILS), Bhubaneswar, and the Indian Institute of Technology (IIT) Bhubaneswar, marks a significant advancement in ...
A promising tuberculosis vaccine candidate, developed by ILS Bhubaneswar and IIT Bhubaneswar, has been transferred to ...
Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...
“To address this critical unmet need, a next-generation HSP Subunit Vaccine has been developed through collaborative research ...
Bhubaneswar and Institute of Life Sciences (ILS) along with National Research Development Corporation (NRDC) o ...
It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...
Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS), along with the ...
Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, claiming 1.23 million lives in 2024 alone, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback